Facebook
X
LinkedIn
Forward| Title | Credit |
Series date |
Member price | Non-member price |
|---|---|---|---|---|
|
If you Build it, They will stay: The Role of the Pediatric Nurse Practitioner in Creating Inclusive Sensory Spaces for Neurodiverse Youth 1.25 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.50 for NAPNAP Members. For non-members, this continuing education activity rate is $25. This course is a recorded presentation for NAPNAP's 2025 National Conference. Discover how pediatric-focused APRNs can revolutionize health care environments by creating inclusive sensory spaces that cater to neurodiverse youth. This presentation will explore innovative design strategies beyond traditional sensory rooms, highlighting the crucial role of APRNs in shaping environments that support and engage both speaking and nonspeaking autistic individuals. Participants will engage in interactive case studies and brainstorming sessions, gaining practical and actionable insights into designing sensory-friendly spaces in primary and acute care settings. NAPNAP’s Developmental Behavioral and Mental Health SIG is pleased to support this activity. |
|
06/30/2025 to 06/30/2027 | $12.50 | $25.00 |
|
Taking a SMART approach to case studies in pediatric asthma management 1.25 NAPNAP Contact Hour of which 0.75 pharmacology content. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.50 for NAPNAP Members. For non-members, this continuing education activity rate is $25. This course is a recorded presentation for NAPNAP's 2025 National Conference. Studies have shown the benefits of SMART (single maintenance and rescue therapy) have improved asthma control, reduced exacerbations, decreased oral steroid use and improved quality of life for patients not controlled with conventional therapy. SMART likely improves long-term asthma control and reduces the potential for over reliance on SABAs (short acting beta agonists). In this presentation, SMART will be presented in the context of case studies, and we will review challenges to implementation of SMART. NAPNAP’s Asthma and Allergy SIG is pleased to support this activity. |
|
06/30/2025 to 06/30/2027 | $12.50 | $25.00 |
|
Emerging Pediatric Infectious Diseases 1.25 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $12.50 for NAPNAP Members. For non-members, this continuing education activity rate is $25. This course is a recorded presentation for NAPNAP's 2025 National Conference. Infectious diseases remain a significant cause of mortality and morbidity globally. The factors contributing to emerging and reemerging infectious diseases are complex including microbial adaptation, environmental, socioeconomic, and political factors, as well as vaccine hesitancy. In a rapidly evolving world, staying well-informed of the latest developments in infectious disease is crucial. This presentation will use a rapid-fire format to deliver critical updates on the epidemiology and clinical presentation of emerging infectious diseases. |
|
06/30/2025 to 06/30/2027 | $12.50 | $25.00 |
|
JPHC CE: Recognition and Management of Pediatric Dental Trauma and Infections 1.0 NAPNAP contact hour. This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Dental emergencies are common during childhood and typically occur due to trauma or infection. The current evidence on managing dental injuries is from a dental perspective, with limited information on treating pediatric dental injuries in medical settings. Proper treatment of infection, correct storage, prompt repositioning, and replantation are essential for successful outcomes, as supported by the latest evidence-based guidelines. Pediatric patients have a better prognosis when proper treatment is provided without delay. Understanding potential issues enables providers to assess the severity of the condition, offer initial guidance and management, and recommend appropriate follow-up dental care. This continuing education activity aims to educate providers on how to care for children with low-acuity dental injuries and infections using an evidence-based approach. J pediatr Health Care. (2026) 40, 451-463. |
|
05/01/2026 to 06/30/2027 | $0.00 | $10.00 |
|
JPHC CE: Use of Atypical Antipsychotics in Pediatric Populations 1.75 NAPNAP contact hour of which 1.75 contain pharmacology content (Rx). This continuing education activity is offered free to NAPNAP Members. For nonmembers, this continuing education activity rate is $10. Atypical antipsychotic medications have served as mainstays in the treatment of pediatric-onset bipolar disorder and schizophrenia and are typically prescribed by psychiatric providers. These medications also have an important role in treating specific behaviors associated with other pediatric diagnoses, including autism spec-trum disorder, disruptive behavior disorders, and tic disorders. Nurse practitioners play an important role in initiating treatment in children who require these drugs and monitoring those who are already prescribed these medications by psychiatric professionals. The pharmacokinetics, pharmacodynamics, and pharmacogenomic implications for aripiprazole, olanzapine, quetiapine, and risperidone are described. This article reviews appropriate approaches to prescribing, monitoring for efficacy and side effects, and considerations when tapering or discontinuing antipsychotic medications. J pediatr Health Care. (2026) 40, 464−474. |
|
05/01/2026 to 06/30/2027 | $0.00 | $10.00 |
|
Overuse of Psychotropic Medications in Children and Youth in Foster Care 0.5 NAPNAP Contact Hour. This continuing education activity is offered at a reduced rate to NAPNAP Members. This continuing education activity rate is $5 for NAPNAP Members. For non- members, this continuing education activity rate is $10. This continuing education activity was reviewed and updated in 2025 to ensure compliance with current clinical standards, updated instructional content and best practices in health care education. Children in foster care are a vulnerable population with unmet health care needs complicated by a history of trauma, making providing comprehensive care difficult for Advanced Practice Providers (APPs). Care for this population is often transient and crisis centered, and an estimated 80% of children in foster care having one or more psychiatric diagnoses. Despite this rate of psychiatric diagnoses, children in foster care are prescribed psychotropic medications at a disproportionately high rate that is more than twice that of Medicaid controls. Stimulants are the most prescribed medication class followed by atypical anti-psychotic medications. A better understanding of the common mental health diagnoses of children in foster care, common medication indications and their monitoring, and available evidence-based treatments are imperative for APPs to care for this population. APPs need to be strong advocates for this vulnerable population to reduce the risk of psychotropic medication overuse and improve overall health outcomes. |
|
07/05/2023 to 07/31/2027 | $5.00 | $10.00 |
|
AAP Evidence-based Vaccine Recommendations 2026 1.0 NAPNAP Contact Hour of which 1.0 contain pharmacology content. While presenting the latest CDC immunization information, Dr. Koslap-Petraco will share real life experiences and case studies to engage and challenge you to educate and vaccinate your patient families, especially those who question the need for vaccines. |
|
07/22/2026 to 07/31/2027 | $0.00 | $0.00 |
|
Pressure Points in Pediatric Vaccines: The Critical Role of Advanced Practice Professionals for Lasting Progress in Vaccine-Preventable Diseases Join us for an educational activity to discuss methods to build trust between HCPs and vaccine-hesitant parents and caregivers. Our expert panelists discuss the importance of evidence-based messaging and effective strategies to counter pediatric vaccine misinformation. |
|
08/01/2026 to 07/31/2027 | $0.00 | $0.00 |
|
Meningococcal Myth Busters: Strategies to Build Vaccine Confidence and Boost Uptake Join us to get up-to-date with the latest data on meningococcal vaccines and recommendations and learn more about risk factors for invasive meningococcal disease. Our expert panelists discuss the importance of evidence-based messaging and effective strategies to counter meningococcal vaccine misinformation. |
|
08/01/2026 to 07/31/2027 | $0.00 | $0.00 |
|
RSV Prevention in Infants and Young Children: Empowering Pediatric NPs to Lead Early Protection RSV remains a leading cause of serious illness in infants and young children—but prevention has entered a new era. With long-acting monoclonal antibodies and maternal vaccination now available, healthcare professionals have powerful tools to reduce severe disease and hospitalizations. This engaging activity equips pediatric NPs with the knowledge and confidence to navigate the evolving RSV prevention landscape—covering the latest evidence, safety and efficacy data, and current immunization guidance for infants and young children. Participants will also strengthen their ability to integrate immunoprophylaxis into care plans and communicate effectively with parents and caregivers to support informed shared decision-making. |
|
08/04/2026 to 07/31/2027 | $0.00 | $0.00 |
|
Human Trafficking: Raising Awareness to Identify Victims in the Clinical Setting Providers must register for a free PedsCE account, and be logged in to watch the webinar and receive the certificate. This course was created in collaboration with NAPNAP Partners for Vulnerable Youth. This continuing education activity is offered free for NAPNAP members and nonmembers. |
|
10/06/2020 to 08/29/2027 | $0.00 | $0.00 |
|
2025 Pediatric Pharmacology Update 1.00 NAPNAP Contact Hour of which 1.00 pharmacology content. This continuing education activity is offered as part of the 2025 Pediatric Pharmacology Bundle. This course is a recorded presentation for NAPNAP's 20255 National Conference. A fast-paced update on pediatric prescribing including newly approved or relabeled pediatric medications, and pediatric pharmacology studies in process. Issues that affect pediatric practice including drug shortages, emerging poisoning hazards, and new guidelines will be discussed. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
Pharmacologic Management of Cardiac Dysrhythmias 1.25 NAPNAP Contact Hour of which 1.25 pharmacology content. This continuing education activity is offered as part of the 2025 Pediatric Pharmacology Bundle. This course is a recorded presentation for NAPNAP's 20255 National Conference. This presentation will focus on the treatment of common dysrhythmias seen in children, specifically pharmacologic options. We will review both inpatient and outpatient management of various dysrhythmias. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
2025 Psychopharmacology Update 2.75 NAPNAP Contact Hour of which 2.75 pharmacology content, 2.75 are Psychopharmacology content and 0.25 are Controlled Substance content. This archived presentation from our 2025 national conference is available only as part of a bundle of pharmacology courses recorded during our 2025 conference in Chicago. Purchase the 2025 Pediatric Pharmacology Bundle and gain access to all five courses. Children and adolescents with behavioral health conditions are commonly seen in all pediatric environments. We will focus on the emerging use of long-acting formulations for management of chronic psychiatric conditions and other new pharmacologic approaches to behavioral health management. This presentation is solely focused on pharmacology and aims to help demystify these medications for the pediatric provider. NAPNAP’s Developmental Behavioral and Mental Health SIG is pleased to support this session. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |
|
New Pediatric Antibiotic Prescribing Guidelines 1.00 NAPNAP Contact Hour of which 1.00 pharmacology content. This archived presentation from our 2025 national conference is available only as part of a bundle of pharmacology courses recorded during our 2025 conference in Chicago. Purchase the 2025 Pediatric Pharmacology Bundle and gain access to all five courses. |
|
08/29/2025 to 08/31/2027 | $0.00 | $0.00 |